Diligence memo · auto-generated · as of July 2, 2026

Trice Medical, Inc.

Trice Medical, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Trice Medical, Inc. operates in Healthtech, based in LAKE FOREST.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Trice Medical, Inc. has raised $124M in disclosed capital across 10 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $41M on 2017-05-25.

Most recent recorded round closed around 2023-07-21.

Valuation (modeled)modeled

Provath models Trice Medical, Inc. at approximately $116M (range $38M–$200M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.24× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 2.9 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 1.4× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 96% of Healthtech peers (2138 compared).

Modeled value ranks above 80% of those peers.

Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Hazel Health, Inc., Health Gorilla, Inc..

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.